Drug Trial Radar · NCT06488664
An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis
Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
422
Actual
Start
Jul 25, 2023
Primary completion
Apr 30, 2025
Study completion Nov 26, 2025
Sponsor
- Lead sponsor
- AO GENERIUMIndustry
- Sponsor type
- Industry
- First posted
- Jul 5, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized single-blind comparative parallel group efficacy and safety study of ustekinumab biosimilar GNR-068 (45 mg) and reference product Stelara® (45 mg) in the treatment of patients with moderate and severe forms of plaque psoriasis. Participants received a subcutaneous dose of ustekinumab 45 mg (GNR-068 or Stelara®) at weeks 0 and 4 weeks then every 12 weeks thereafter until week 28 and then all patients receive GNR-068 45 mg. For patients with partially respond to the initial regimen the regimen can be adjusted.
Conditions
- Plaque Psoriasis
Interventions
GNR-068Biological
GNR-068 was administered subcutaneously at weeks 0 and 4 weeks then every 12 weeks thereafter until week 52.
Stelara®Biological
Stelara® was administered subcutaneously at weeks 0 and 4 weeks then every 12 weeks thereafter until week 28 and then all patients receive GNR-068 45 mg until week 52.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of subjects with Psoriasis Area and Severity Index (PASI) Score of 75 Percent or AboveTime frame: Week 12
Locations
34 sites in 1 country. Site status is shown where the registry gives one.
Federal State Budgetary Educational Institution of Higher Education "Altai State Medical University" of the Ministry of Health of the Russian Federation
Barnaul, Barnaul, Russia
State budgetary healthcare institution "Chelyabinsk Regional Clinical Dermatovenerological Dispensary"
Chelyabinsk, Chelyabinsk Oblast, Russia
Limited Liability Company "Ecology of Health"
Chelyabinsk, Chelyabinsk Oblast, Russia
State budgetary institution of the Sverdlovsk region "Ural Research Institute of Dermatovenereology and Immunopathology"
Yekaterinburg, Ekaterinburg, Russia
Limited Liability Company "Alliance Biomedical - Ural Group"
Izhevsk, Izhevsk, Russia
Federal State Budgetary Educational Institution of Higher Education "Kirov State Medical University" of the Ministry of Health of the Russian Federation (FSBEI HE Kirov State Medical University of the Ministry of Health of Russia))
Kirov, Kirov Oblast, Russia
Limited Liability Company "Available Polyclinic"
Murino, Leningradskaya Oblast', Russia
State health care institution "Regional Dermatovenerological Dispensary"
Lipetsk, Lipetsk Oblast, Russia
Limited Liability Company "OLLA-MED"
Moscow, Moscow, Russia
Federal State Budgetary Institution "Research Institute of Rheumatology named after V.A. Nasonova"
Moscow, Moscow, Russia
Limited Liability Company "Firma ORIS"
Moscow, Moscow, Russia
State budgetary healthcare institution of the city of Moscow "Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology of the Moscow Health Department"
Moscow, Moscow, Russia
Federal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation (FSBEI HE "Russian University of Medicine" of the Ministry of Health of Russia)
Moscow, Moscow, Russia
State budgetary healthcare institution of the Moscow region "Moscow Regional Research Clinical Institute named after M.F. Vladimirsky"
Moscow, Moscow, Russia
Limited Liability Company "Family Clinic No. 4"
Korolyov, Moscow Oblast, Russia
Limited Liability Company "Medical Center "Healthy Family"
Novosibirsk, Novosibirsk Oblast, Russia
Federal State Budgetary Educational Institution of Higher Education Orenburg State Medical University of the Ministry of Health of Russia
Orenburg, Orenburg Oblast, Russia
State budgetary institution of the Ryazan region "Regional clinical dermatovenerological dispensary"
Ryazan, Ryazan Oblast, Russia
Limited Liability Company "Clinic of Skin Diseases Pierre Wolkenstein"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "International Medical Center"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "Medical Technologies" LLC "Medical Technologies"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "Health Energy"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "Interleukin"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "Institute of Medical Research"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "Research Center Eco-Safety"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "PiterKlinika"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "ArsVite North-West"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "Curator"
Saint Petersburg, Sankt-Peterburg, Russia
Private medical institution "Euromedservice"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "MEDINET"
Saint Petersburg, Sankt-Peterburg, Russia
Limited Liability Company "SB Clinic of Cosmetology"
Saratov, Saratov Oblast, Russia
Regional state budgetary healthcare institution "Smolensk Dermatovenerological Dispensary"
Smolensk, Smolensk Oblast, Russia
Limited Liability Company Medical Center "Azbuka Health"
Kazan', Tatarstan Republic, Russia
State Budgetary Healthcare Institution Ulyanovsk area Clinical Hospital
Ulyanovsk, Ulyanovsk Oblast, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.